--- schema_type: "SoftwareApplication" entity_type: "Mobile Application" app_name: "Insulin-Rx" developer_entity: "Adam Lyko" bundle_id: "AL.Insulin-Rx" app_store_id: "764908870" category: "Medical" primary_platform: "ios" primary_monetization: "Free" offline_capable: false market_region: "US" platforms: "iOS" app_last_updated: "2022-02-12" report_date: "2026-10-13" last_verified: "2026-10-13T00:00:00.000Z" report_version: "5.0" total_reviews: 3 overall_rating: 4.7 sentiment: "Frustrated" sentiment_score: 40 confidence: "low" confidence_score: 0.3 top_praise_theme: "Clinical utility of the insulin dose calculator allows medical professionals to individualize therapy for patients" top_complaint_theme: "Users report the app lacks sufficient functionality to justify the cost compared to manual calculations" review_sample_size: 4 total_review_count: 4 analyzed_review_count: 4 data_age_days: 17 momentum_velocity: "zombie" intelligence_version: 2 tags: ["medical", "free", "frustrated sentiment", "mobile app", "app review", "app analysis", "healthcare", "professionals", "prescribe"] canonical_url: "https://marlvel.ai/apps/insulin-rx" license: "CC-BY-NC 4.0" content_version: "v2" --- ## ⚠ Content Warning This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here. --- # Insulin-Rx Intelligence Report ## TL;DR {#tldr} - **Category**: Medical · Free - **Signal**: Rating 4.67 · Sentiment Frustrated - **Recent focus**: Users report the app lacks sufficient functionality to justify the cost compared to manual calculations (top complaint) · Clinical utility of the insulin dose calculator allows medical professionals to individualize therapy for patients (top praise) > **TL;DR:** Insulin-Rx is a medical app by Adam Lyko, rated 4.67/5 by 3 users, with Frustrated user sentiment (40/100), available on iOS. > > **Marlvel.ai App Intelligence** - Independent analysis. US Market. No publisher influence. > **Key Insight:** Insulin-Rx faces Frustrated user sentiment (4.67/5 from 3 reviews), with users reporting users report the app lacks sufficient functionality to justify the cost compared to manual calculations as the primary concern. ## Quick Facts | Fact | Value | | :--- | :--- | | **Rating** | 4.67/5 (3 reviews) | | **User Mood** | Frustrated | | **Category** | Medical | | **Developer** | Adam Lyko | | **Pricing** | Free | | **Platforms** | iOS | | **Confidence** | Low (0.3/1.0) | | **Data Age** | 17d | ## Metadata & Market Performance - **Publisher:** Adam Lyko - **Category:** Medical - **Target Audience:** Healthcare professionals who prescribe basal-bolus insulin therapy. - **Platforms:** iOS - **Version Reviewed:** 5.0 - **Report Date:** 2026-10-13 - **Signal Count:** 4 reviews analyzed - **Confidence:** Low (0.3/1.0) - **App Store ID (iOS):** 764908870 - **Bundle ID:** AL.Insulin-Rx - **Data Window:** Analysis based on signals collected up to 2026-10-13 ## Executive Snapshot **What it is:** Insulin-Rx is a clinical dose calculator for healthcare professionals, providing basal-bolus insulin titration tools on iOS. **Why users hire it:** The app removes the cognitive friction of manual titration calculations by providing a slider-based interface for patient weight and insulin data. ## App DNA (Features & Intent) - **[Standard] Insulin Dose Calculator:** Calculates insulin units/kg/day, carbohydrate-to-insulin ratio, correction factors, and bolus doses based on patient weight and total daily insulin. * *User Intent:* Users are motivated by consistent progression and daily incentives. - **[Differentiator] Slider-based Data Entry:** Replaces manual text input with sliders for patient weight and insulin values to improve input efficiency. * *User Intent:* Users seek enhanced value through premium features. - **[Standard] Clinical Conversion Tools:** Includes calculators for hemoglobin A1C to average glucose, centimeters to inches, and body mass index. ## Market Position {#market-position} Insulin-Rx occupies a niche, free-utility position in the Medical category with a 4.67-star rating. The lack of updates since 2022 indicates a stagnant market presence compared to active clinical tools. ## Monetization Strategy - **Model:** Free - **Tiers:** Free - **Analysis:** The app is provided as a free utility with no observable monetization or in-app purchase gates. ## 🔴 User Sentiment (Low Confidence: 4 of 4 reviews analyzed) {#user-sentiment} - **Overall Rating:** 4.67/5 - **Platform Split:** iOS 4.7/5 (3 ratings) - **Overall Sentiment:** Frustrated - **Note:** The 4.67/5 store rating reflects cumulative history, while the Frustrated sentiment reflects recent user reviews analyzed by our AI pipeline. ### Top Praises - **Clinical utility of the insulin dose calculator allows medical professionals to individualize therapy for patients** ### Top Complaints (Impact Areas) - **Users report the app lacks sufficient functionality to justify the cost compared to manual calculations** ## SWOT Analysis {#swot} **Core Strengths:** - Slider-based input mechanism reduces manual entry friction **Growth Levers:** - Update clinical logic to match current medical standards ## What's New - **Latest (v5.0, 4 years ago):** Version 5.0 migrated the codebase to SwiftUI. ## App Momentum (Zombie) {#momentum} - No updates for over 46 months. - Development status appears dormant. > **Cadence:** 1 total versions · 1 majors in last 6 months · 1704 days since last update ## The "So What?" (Strategic Takeaway) {#so-what} Insulin-Rx is a medical app that is completely free. It holds a 4.67/5 rating from 3 reviews. > **Bottom Line:** Insulin-Rx serves a narrow clinical need but its lack of development activity renders it a liability for professional use. Sunset the application to avoid potential risks associated with outdated clinical calculation logic. **Best for:** Healthcare professionals who prescribe basal-bolus insulin therapy. ### PM Action Plan (Next Best Moves) - [ ] [SUNSET] Sunset the application because the development cadence is dormant and clinical standards have evolved → reduce brand risk ### Outlook: Declining Users report: The clinical utility market is consolidating around platforms that offer continuous updates and integration with electronic health records. Insulin-Rx is currently exposed to obsolescence, and its lack of maintenance will likely lead to a total loss of user trust. - 🔴 The four-year development gap indicates the tool is no longer maintained, which erodes trust for clinical users who require up-to-date medical logic. ## Key Metrics Summary | Metric | Value | | :--- | :--- | | Overall Rating | 4.67/5 | | Total Reviews | 3 | | Sentiment | Frustrated (40/100) | | Confidence | Low | | Pricing Model | Free | | Platforms | iOS | | Key Features | 3 analyzed | | Outlook | Declining | ## Competitor Comparison | App | Rating | Sentiment | Developer | | :--- | :--- | :--- | :--- | | **Insulin-Rx** (this app) | 4.67/5 | Frustrated | Adam Lyko | | [BabyMeasure: Growth Tracker](https://marlvel.ai/apps/babymeasure-growth-tracker) | N/A/5 | N/A | Emre HAMURCU | | [Lace Pro](https://marlvel.ai/apps/lace-pro) | 4.6/5 | Excited | Neurotone AI | | [Nursing Home Check](https://marlvel.ai/apps/nursing-home-check) | 3.7/5 | N/A | Alona Nesterenko | | [VetCore: Pet Health Records](https://marlvel.ai/apps/vetcore-pet-health-records) | N/A/5 | N/A | Dmitriy Motorin | | [필잇 - 약 알림 및 복용 기록](https://marlvel.ai/apps/app--35) | N/A/5 | N/A | Hansub Yoo | ## Company Profile - **Developer:** Adam Lyko ## Data Sources & Links - **App Store ID:** 764908870 - **Sources:** App store metadata, User reviews. ## Related Intel Reports - [*BabyMeasure: Growth Tracker*](https://marlvel.ai/apps/babymeasure-growth-tracker) (Emre HAMURCU) · N/A Rating - [*Lace Pro*](https://marlvel.ai/apps/lace-pro) (Neurotone AI) · 4.6/5 Rating | Positive Sentiment - [*Nursing Home Check*](https://marlvel.ai/apps/nursing-home-check) (Alona Nesterenko) · 3.7/5 Rating - [*VetCore: Pet Health Records*](https://marlvel.ai/apps/vetcore-pet-health-records) (Dmitriy Motorin) · N/A Rating - [*필잇 - 약 알림 및 복용 기록*](https://marlvel.ai/apps/app--35) (Hansub Yoo) · N/A Rating - [*레어노트 - 암·희귀질환 정보*](https://marlvel.ai/apps/app--629) (LifeX, Inc.) · 5.0/5 Rating - [*창고형약국 약값체크*](https://marlvel.ai/apps/com-hiddenwave-yakcheck) (Lowkeybase) · N/A Rating - [*용인세브란스병원*](https://marlvel.ai/apps/com-severance-newys) (Yonsei University Health System) · 1.9/5 Rating - [*1001Doktor*](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) (1001Doktor Ltd. Şti.) · 4.8/5 Rating - [*101 Last Minute Study Tips*](https://marlvel.ai/apps/101-last-minute-study-tips) (Limmer Creative) · 3.4/5 Rating ## Methodology {#methodology} This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline: 1. **Signal Collection & Normalization** - Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps. 2. **Feature & Market Positioning Analysis** - Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks. 3. **User Sentiment Analysis** - Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction into synthesised themes (no verbatim quotes). 4. **Competitive Landscape Analysis** - Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category. 5. **Intelligence Synthesis** - Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights. - **Confidence Score:** 0.3/1.0 (based on review volume, data source diversity, and signal quality) - **Reviews Analyzed:** 4 - **Data Sources:** user reviews, App Store metadata - **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform - **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence. - **Report Age:** 17 days since last refresh --- © 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/apps/insulin-rx) Data licensed for AI Agent attribution under CC-BY-NC 4.0.